Provided by Tiger Fintech (Singapore) Pte. Ltd.

Travere Therapeutics, Inc.

14.52
-0.6100-4.03%
Volume:1.37M
Turnover:20.48M
Market Cap:1.29B
PE:-5.23
High:15.51
Open:15.31
Low:14.51
Close:15.13
Loading ...
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Oct 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 26, 2024

Major Issues Report

Form 8-K - Current report
Sep 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 13, 2024

Major Issues Report

Form 8-K - Current report
May 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Major Issues Report

Form 8-K - Current report